| Disease/Panel Name | Gene Name | Targeted Region | Method | UBB Record |
| Thrombophilia Panel | F2, FV Leiden, MTHFR A1298C, MTHFR C677T | – | Mini Sequencing | Yes |
| Cardiovascular Diseases Panel (CVD) | Faktör II protrombin (G20210A), Faktör V (G1691A ve H1299R), | Mini Sequencing | Yes | |
| MTHFR (C677T ve A1298C), Faktör XIII (V34L), β-Fibrinojen (-455 G-A), | ||||
| PAI-1 (4G/5G), HPA-1 (a/b), ACE (I/D), ApoB (R3500Q), ApoE (e2/e3/e4) | ||||
| Familial Mediterranean Fever (FMF) 15 Mutation Panel | E148Q, R202Q, P369S, M694V+L, I692del, M694I, K695R+M, | Exon 2-3-5-10 | Mini Sequencing | Yes |
| V726A, A744S, R761H | ||||
| ABL1 Imatinib Resistance | G250E, Y253H, E255, T315I, F317L, M351T | Exon 4-6 | Mini Sequencing | Yes |
| Kras 15 Mutation Panel | COD12,13 and COD61 all mutation | Exon 2-3 | Mini Sequencing | Yes |
| Braf V600 Mutation Panel | BRAF | V600D,E,G,K,R,M | Mini Sequencing | Yes |
| Osteoporosis Panel | COL1A1, ESR1, VDR, CTR | SPI, XBaI, PvuII, BsmI, FokI, AluI | Mini Sequencing | |
| 5-fluorouracil toxicity | DPD*2A | IVS14+1G>A | Mini Sequencing | |
| CYP2C9 | CYP2C9 | Alleles of *1, *2, *3, *4, *5 | Mini Sequencing | |
| CYP2C19 | CYP2C19 | Alleles of *1, *2, *3, *4, *17 | Mini Sequencing | |
| CYP1A2 | CYP1A2 | Alleles of *1A, *1F | Mini Sequencing | |
| CYP3A4 | CYP3A4 | Alleles of *1A, *1B | Mini Sequencing | |
| FLT3 ITD, D835 | FLT3 | Mutations of ITD and D835 | Mini Sequencing + Fragment Analysis | |
| Gaucher | GBA | Point Mutation | Mini Sequencing | |
| Achondroplasia – Hypochondroplasia -TD1-TD2 | FGFR3 | Point Mutation | Mini Sequencing | |
| LHON | MT-ND4 | Point Mutation | Mini Sequencing | |
| MT-ND1 | Mini Sequencing | |||
| MT-ND6 | Mini Sequencing | |||
| A1AT (Alpha-1 antitrypsin) | SERPINA (E264V, E342K) | Point Mutation | MiniSequencing | |
| Six-mercaptopurine sensitivity | TPMT | *1, *2, *3A, *3B, *3C | Mini Sequencing |
